Pulmonx Corporation (LUNG) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts LUNG Hot Sheet
Join SI Premium – FREE
Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $20.15 million.
For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Avis Budget Group reaches $650M settlement with Pentwater Capital
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
